Childress Capital Advisors LLC Acquires Shares of 6,731 CVS Health Corporation (NYSE:CVS)

Childress Capital Advisors LLC acquired a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,731 shares of the pharmacy operator's stock, valued at approximately $456,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CVS. Cullinan Associates Inc. raised its position in shares of CVS Health by 12.2% in the first quarter. Cullinan Associates Inc. now owns 44,459 shares of the pharmacy operator's stock valued at $3,012,000 after buying an additional 4,841 shares during the last quarter. Center For Asset Management LLC purchased a new position in shares of CVS Health during the 1st quarter worth approximately $219,000. Connective Portfolio Management LLC purchased a new position in shares of CVS Health during the 1st quarter worth approximately $813,000. Praxis Investment Management Inc. boosted its position in CVS Health by 32.3% in the 1st quarter. Praxis Investment Management Inc. now owns 34,194 shares of the pharmacy operator's stock valued at $2,317,000 after buying an additional 8,340 shares during the period. Finally, Stonegate Investment Group LLC boosted its position in CVS Health by 103.3% in the 1st quarter. Stonegate Investment Group LLC now owns 18,495 shares of the pharmacy operator's stock valued at $1,253,000 after buying an additional 9,399 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now owns 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is currently owned by insiders.

CVS Health Stock Performance

Shares of CVS opened at $66.69 on Friday. The company has a 50-day moving average of $64.92 and a two-hundred day moving average of $60.42. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a market cap of $84.36 billion, a P/E ratio of 15.92, a PEG ratio of 0.95 and a beta of 0.56. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 earnings per share. As a group, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CVS. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. UBS Group lifted their price objective on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and issued a $84.00 target price (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.